Alzheimer Disease clinical trials

Access comprehensive clinical trial information for Alzheimer Disease through Pure Global AI's free database. This collection includes 673 clinical trials across multiple phases including N/A, Phase 1, Phase 2. Currently, 164 trials are actively recruiting participants.

Research for Alzheimer Disease is being conducted in United States of America, France, China and 7+ other countries. Leading sponsors include Wyeth is now a wholly owned subsidiary of Pfizer and Pfizer. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 673 clinical trials studying Alzheimer Disease, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Wyeth is now a wholly owned subsidiary of Pfizer, Pfizer, Eli Lilly and Company, among others.